221 related articles for article (PubMed ID: 26111032)
1. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.
Maes T; Mascaró C; Ortega A; Lunardi S; Ciceri F; Somervaille TC; Buesa C
Epigenomics; 2015; 7(4):609-26. PubMed ID: 26111032
[TBL] [Abstract][Full Text] [Related]
2. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases.
Mao F; Shi YG
Adv Exp Med Biol; 2023; 1433():15-49. PubMed ID: 37751134
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
Hosseini A; Minucci S
Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into histone lysine demethylation.
Hou H; Yu H
Curr Opin Struct Biol; 2010 Dec; 20(6):739-48. PubMed ID: 20970991
[TBL] [Abstract][Full Text] [Related]
5. Targeting histone lysine demethylases - progress, challenges, and the future.
Thinnes CC; England KS; Kawamura A; Chowdhury R; Schofield CJ; Hopkinson RJ
Biochim Biophys Acta; 2014 Dec; 1839(12):1416-32. PubMed ID: 24859458
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of histone lysine demethylases in prostate cancer.
Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD
Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylases in neurodevelopment and neurodegenerative diseases.
Wang H; Guo B; Guo X
Int J Neurosci; 2023 Oct; ():1-11. PubMed ID: 37902510
[TBL] [Abstract][Full Text] [Related]
8. KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
Ismail T; Lee HK; Kim C; Kwon T; Park TJ; Lee HS
Epigenetics Chromatin; 2018 Jun; 11(1):33. PubMed ID: 29921310
[TBL] [Abstract][Full Text] [Related]
9. Lysine Demethylation in Pathogenesis.
Cao J; Yan Q
Adv Exp Med Biol; 2023; 1433():1-14. PubMed ID: 37751133
[TBL] [Abstract][Full Text] [Related]
10. LSD1: more than demethylation of histone lysine residues.
Perillo B; Tramontano A; Pezone A; Migliaccio A
Exp Mol Med; 2020 Dec; 52(12):1936-1947. PubMed ID: 33318631
[TBL] [Abstract][Full Text] [Related]
11. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
Laurent B; Shi Y
Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
[TBL] [Abstract][Full Text] [Related]
12. The role of histone demethylases in cancer therapy.
Hoffmann I; Roatsch M; Schmitt ML; Carlino L; Pippel M; Sippl W; Jung M
Mol Oncol; 2012 Dec; 6(6):683-703. PubMed ID: 22902149
[TBL] [Abstract][Full Text] [Related]
13. Targeting histone demethylases as a potential cancer therapy (Review).
Diao W; Zheng J; Li Y; Wang J; Xu S
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35801593
[TBL] [Abstract][Full Text] [Related]
14. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
15. A scintillation proximity assay for histone demethylases.
Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ
Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373
[TBL] [Abstract][Full Text] [Related]
16. The role and prospect of lysine-specific demethylases in cancer chemoresistance.
Song YQ; Yang GJ; Ma DL; Wang W; Leung CH
Med Res Rev; 2023 Sep; 43(5):1438-1469. PubMed ID: 37012609
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
He X; Zhang H; Zhang Y; Ye Y; Wang S; Bai R; Xie T; Ye XY
Eur J Med Chem; 2022 Mar; 231():114143. PubMed ID: 35101649
[TBL] [Abstract][Full Text] [Related]
18. Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells.
Hino S; Kohrogi K; Nakao M
Cancer Sci; 2016 Sep; 107(9):1187-92. PubMed ID: 27375009
[TBL] [Abstract][Full Text] [Related]
19. In vitro histone demethylase assays.
Kokura K; Sun L; Fang J
Methods Mol Biol; 2015; 1288():109-22. PubMed ID: 25827878
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers.
Dorna D; Paluszczak J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
